Sunshine Act. Each of the Company and Executive acknowledge that certain state or federal laws now or in the future may require Novavax to disclose information regarding compensation, funding, gifts, payments or other remuneration (“Remuneration”) provided to physicians and other members of the health care community. Novavax may report information about Remuneration provided under this Agreement as required by applicable law. Once reported, such information will be publicly accessible.
Sunshine Act. Each Party acknowledges that, under the provisions of Section 1128G of the Social Security Act, 42 U.S.C. § 1320a-7h and other similar provisions of Applicable Law, such Party may be required to disclose certain payments and other transfers of value provided to health care professionals and institutions, including payments, reimbursements, materials or equipment made or provided under or in connection with this Agreement or the development plans. Each Party will provide the other Party with all reasonable information in its Control related to the activities hereunder necessary for the other Party to comply with such Applicable Laws in the form reasonably requested by the requesting Party and at such times as the requesting Party may reasonably request to satisfy its obligations.
Sunshine Act. Each Party shall report any reportable payments or transfers of value that it makes in connection with this Agreement to covered recipients pursuant to §6002 of the Affordable Care Act of 2010, and other similar laws.
Sunshine Act. In compliance with specific Donor reporting requirements, OMeGA will report to Donor(s) such information Donor requires in order to achieve compliance under the Sunshine Act, all in connection with this grant.
Sunshine Act. Allergan and Assembly acknowledge that, under the provisions of Section 1128G of the Social Security Act, 42 U.S.C. § 1320a-7h and other similar provisions of applicable Law, Allergan and Assembly may be required to disclose certain payments and other transfers of value provided to health care professionals and institutions, including payments, reimbursements, Materials or equipment made or provided under or in connection with this Agreement or the R&D Plan. Each of Assembly and Allergan will provide the other or its designee/s with all information necessary for the other to comply with such applicable Laws in the form reasonably requested by the requesting Party and at such times as the requesting Party may reasonably request to satisfy its obligations.
Sunshine Act. In compliance with reporting requirements, Administrator will report to Donor(s) such information Donor requires in order to achieve compliance under the Sunshine Act, all in connection with this grant.
Sunshine Act. The parties acknowledge that certain state or federal laws now or in the future may require Sponsor to disclose information regarding compensation, funding, gifts, payments or other remuneration (“Remuneration”) provided to physicians and other members of the health care community. Sponsor may report information about Remuneration provided under this Agreement as required by applicable law, and shall notify Institution if such reporting occurs. Once reported, such information may be publicly accessible.
Sunshine Act. Illumina and Partner acknowledge that they both may be “Applicable Manufacturers” pursuant to the Physician Payment Sunshine Act and may have certain duties to track and report payments and transfers of value to “Covered Recipients”, as those terms are defined by the Centers for Medicare & Medicaid Services, or a successor entity thereto. To the extent either Party has reporting obligations under the Physician Payment Sunshine Act, upon the reasonable request of the reporting Party the other Party will provide such reporting Party with complete and accurate information about payments or transfers of value in relation to the activities under this Agreement that are reportable thereunder. CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE KURA ONCOLOGY, INC. HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO KURA ONCOLOGY, INC. IF PUBLICLY DISCLOSED.
Sunshine Act. The Parties acknowledge and agree that any direct or indirect payment or transfer of value, as defined in the Physician Payments Sunshine Act (42 U.S.C. § 1320a-7h) and its implementing regulations (42 C.F.R. § 403.900 et seq.), including any compensation, reimbursement for expenses, meals, travel, and medical journal reprints to any teaching hospital in the United States or any physician, physician assistant, nurse practitioner, clinical nurse specialist, certified registered nurse anesthetist, or certified nurse-midwife who is not a bona fide employee of a Party that is licensed to practice in the United States (each, a “Covered Recipient”) is subject to transparency reporting requirements, including disclosure on the federal Open Payments website. The Parties shall comply with such law in their performance of this Agreement.
Sunshine Act. Recipient acknowledges and agrees that the transfer of the Materials by AstraZeneca to the Recipient may be deemed as a transfer of value as defined in the U.S. Physician Payment Sunshine Act (42 USC §1320(e)(10)), and implementing regulations (42 CFR §§403.900 et seq.). Recipient further acknowledges and agrees that such transfer may be subject to transparency reporting requirements, including disclosure on AstraZeneca’s website.
